Skip to content

A clinical study to compare the effect of application of medicated paste followed by therapeutic purgation and application of medicated paste and pouring medicated fermented liquid followed by therapetic purgation in treating rheumatoid arthritis

AN OPEN LABEL DOUBLE ARM CLINICAL STUDY TO COMPARE THE EFFECT OF AGNILEPA FOLLOWED BY VIRECHANA KARMA AND AGNILEPA, DHANYAAMLA KAYASEKA FOLLOWED BY VIRECHANA KARMA IN AMAVATA VIS-A-VIS RHEUMATOID ARTRITIS - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/02/031026
Enrollment
40
Registered
2021-02-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

Intervention1: AGNILEPA VIRECHANA KARMA: SUBJECTS WHO FULLFILLING INCLUSION CRITERIA IS SUBJECTED TO AGNILEPA FOLLOWED BY VIRECHANA KARMA external application still appearence of samyaka langana laksh

Sponsors

Dr shashikala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects presenting with the lakshanas of Amavata Subjects presenting with the clinical features of Rheumatoid Arthritis Subjects fit for Lepa Kayaseka Snehapana Virechana karma Subjects of either gender Age group of 20-60 years

Exclusion criteria

Exclusion criteria: subjects with any other systemic disorders that interfere with the course of treatment subjects who are unfit for lepa kayaseka snehapana virechana karma

Design outcomes

Primary

MeasureTime frame
Comparision of effect of agnilepa virechana karma and agnilepa dhanyaamla kayaseka virechana karmaTimepoint: 17 to 25 days

Secondary

MeasureTime frame
NILTimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDr Lolashri S J

Sri kalabyraveshwara swamy ayurvedic medical college hospital and research centre

sjlolashri@gmail.com9738671971

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026